
-
Google must open Android to rival app stores: US court
-
Amazon profits surge 35% as AI investments drive growth
-
Zelensky urges allies to seek 'regime change' in Russia
-
Trump envoy to inspect Gaza aid as pressure mounts on Israel
-
US theater and opera legend Robert Wilson dead at 83
-
EA shooter 'Battlefield 6' to appear in October
-
Heavyweight shooter 'Battlefield 6' to appear in October
-
Justin Timberlake says he has Lyme disease
-
Atkinson and Tongue strike as India struggle in England decider
-
US theater and opera auteur Bob Wilson dead at 83
-
Trump envoy to visit Gaza as pressure mounts on Israel
-
In Darwin's wake: Two-year global conservation voyage sparks hope
-
Microsoft valuation surges above $4 trillion as AI lifts stocks
-
Verstappen quells speculation by committing to Red Bull for 2026
-
Study reveals potato's secret tomato past
-
Trump's envoy in Israel as Gaza criticism mounts
-
Squiban solos to Tour de France stage win, Le Court maintains lead
-
Max Verstappen confirms he is staying at Red Bull next year
-
Mitchell keeps New Zealand on top against Zimbabwe
-
Vasseur signs new contract as Ferrari team principal
-
French cities impose curfews for teens to curb crime
-
Seals sing 'otherworldly' songs structured like nursery rhymes
-
India captain Gill run out in sight of Gavaskar record
-
Trump's global trade policy faces test, hours from tariff deadline
-
Study reveals potato's secret tomato heritage
-
Wirtz said I would 'enjoy' Bayern move, says Diaz
-
West Ham's Paqueta cleared of betting charges
-
AI gives stocks a lift, dollar mixed tracking Fed, tariffs
-
Authorities abandon recovery of German Olympian killed in Pakistan
-
Talks over France, Lions game 'progressing': Benazzi
-
Popovici ready to hit the beach after world swim sprint double
-
Magic Marchand adds gold to world record as McIntosh wins again
-
Sweden jihadist jailed for life over Jordan pilot burned alive
-
Zelensky signs bill ensuring anti-graft agencies' 'independence'
-
Sleepless in Singapore: Marchand wins gold, day after world record
-
England make early double strike in India series decider
-
Popovici wins 100m freestyle world gold for sprint double
-
Marchand wins 200m medley gold, day after world record
-
Thousands of Afghans scramble for chance to work in Qatar
-
Trump's envoy arrives in Israel as Gaza criticism mounts
-
McIntosh powers to third gold of worlds, 12-year-old Yu fourth
-
Hong Kong sees 3.1% growth in second quarter
-
Stocks, dollar mixed tracking Fed, tariffs, results
-
World Athletics brings in gene tests for female category eligibility
-
Trump says tariffs are making US 'great & rich' again
-
Pakistan opposition leader given 10 years for Imran Khan protests
-
India's Bumrah out of Oval finale as England bowl in fifth Test
-
Rights groups urge Nepal to reverse Telegram ban
-
BMW says can weather tariff storm despite profit plunge
-
Zelensky urges allies to push for 'regime change' in Russia
SCU | 0% | 12.72 | $ | |
RBGPF | 0.52% | 74.42 | $ | |
RYCEF | 7.62% | 14.18 | $ | |
CMSC | 1.09% | 22.85 | $ | |
BCC | -1.29% | 83.81 | $ | |
NGG | 0.28% | 70.39 | $ | |
BCE | -0.86% | 23.33 | $ | |
CMSD | 0.9% | 23.27 | $ | |
RIO | 0.47% | 59.77 | $ | |
SCS | 0% | 10.33 | $ | |
JRI | 0.15% | 13.13 | $ | |
RELX | 0.21% | 51.89 | $ | |
VOD | -2.31% | 10.81 | $ | |
AZN | -4.79% | 73.09 | $ | |
BTI | 0.97% | 53.68 | $ | |
GSK | -4.9% | 37.15 | $ | |
BP | -0.31% | 32.15 | $ |

Adding peanuts to young children's diet can help avoid allergy: study
Including peanuts in children's diets early in life could help stave off allergies against the legume, which can be fatal and affect swathes of youngsters globally, according to a new study Friday.
Researchers found that introducing peanut products to babies and infants, and gradually increasing exposure, led to greater tolerance for the common allergen.
The peer-reviewed study, published in The Lancet, involved 146 peanut-allergic children aged between zero and three over two-and-a-half years.
Of the group, 96 were given peanut protein powder every day, with the dose increasing progressively to the equivalent of six peanuts. The other children received a placebo of oat flour.
Twenty of the children who received peanut powder showed allergy remission, meaning no allergic reaction occurred six months after the therapy ended.
One child in the placebo group showed remission.
Six months after the treatment, the children in remission could tolerate a dose equivalent to 16 peanuts.
An additional 20 children who received peanut powder were considered 'desensitised', meaning they had a higher allergic threshold but were not considered in remission.
These children could tolerate a dose equivalent to between six and 12 peanuts six months after the treatment ended.
The youngest children in the study experienced remission the most often, and the best results were in those under 12 months.
"Very early interventions may provide the best opportunity to achieve remission", said co-author Stacie Jones.
- 'Considerable burden' -
Peanut allergies affect two percent of children in Western countries, according to the study, and can last a lifetime.
Affected children must avoid eating peanuts and have self-injectable adrenaline available to fight allergic shocks, which can be fatal if they are accidentally exposed.
Exposure can even occur when a child hugs someone who has just consumed peanuts.
"There are no treatment options, resulting in a considerable burden on allergic children and their caregivers to avoid accidental exposure," said co-author Wesley Burks.
"In severe cases, this can restrict peanut-allergic children's freedoms, particularly when it comes to navigating daycare or schools and public spaces where access to a safe diet is in jeopardy," he added.
Previous studies have produced similar results but the length of the latest studies makes it unique.
Although it provided important results, it may not reflect the behaviour of the children's bodies in real-world conditions.
The study was conducted under close medical supervision, and adrenaline injections were administered on 21 children during the trial.
Y.Nakamura--AMWN